The strong relationship between MXI1 and immunity and carcinogenesis in PRAD was largely supported by the fact that MXI1 was significantly more increased than MXD3 in all types of identified cells, including the close association of MXI1 with lymphatic endothelial cells, adipose stem cells, and iPS cells. Here, MXD3 is linked to prostate adenocarcinoma.